Response to treatment of myasthenia gravis according to clinical subtype

about

Malignant thymoma with metastasis associated with paraneoplastic myasthenia gravis.Efficacy and Safety of the TCM Qi-Supplementing Therapy in Patients with Myasthenia Gravis: A Systematic Review and Meta-Analysis.Myasthenia gravis as a prognostic marker in patients with thymoma.

P2860

Q42207288-211DED2D-1BF0-4F4F-B0D0-FBE242FB04C4 Q48247212-84CE46EE-B3A8-458B-B81F-C9325B540F49 Q55615736-393381A0-6558-4D52-B011-22B226E054FA

P2860

Response to treatment of myasthenia gravis according to clinical subtype

Item

http://www.wikidata.org/entity/Q36195346

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Response to treatment of myasthenia gravis according to clinical subtype

@ast

Response to treatment of myasthenia gravis according to clinical subtype

@en

type

Item

label

Response to treatment of myasthenia gravis according to clinical subtype

@ast

Response to treatment of myasthenia gravis according to clinical subtype

@en

prefLabel

Response to treatment of myasthenia gravis according to clinical subtype

@ast

Response to treatment of myasthenia gravis according to clinical subtype

@en

P1476

Response to treatment of myasthenia gravis according to clinical subtype

@en

P2093

Akiyuki Uzawa

http://www.w3.org/2001/XMLSchema#string

Emiko Tsuda

http://www.w3.org/2001/XMLSchema#string

Hidekazu Suzuki

http://www.w3.org/2001/XMLSchema#string

Hiroyuki Murai

http://www.w3.org/2001/XMLSchema#string

Masashi Aoki

http://www.w3.org/2001/XMLSchema#string

Masayuki Masuda

http://www.w3.org/2001/XMLSchema#string

Naoki Kawaguchi

http://www.w3.org/2001/XMLSchema#string

Naoya Minami

http://www.w3.org/2001/XMLSchema#string

Shingo Konno

http://www.w3.org/2001/XMLSchema#string

Tetsuya Akaishi

http://www.w3.org/2001/XMLSchema#string

P2860

The MG Composite: A valid and reliable outcome measure for myasthenia gravis.

Less is more, or almost as much: a 15-item quality-of-life instrument for myasthenia gravis.

Early fast-acting treatment strategy against generalized myasthenia gravis.

Insights into the classification of myasthenia gravis.

The features of myasthenia gravis with autoantibodies to MuSK.

Neuromuscular junction autoimmune disease: muscle specific kinase antibodies and treatments for myasthenia gravis.

Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity

MuSK IgG4 autoantibodies cause myasthenia gravis by inhibiting binding between MuSK and Lrp4.

Autoimmune myasthenia gravis.

Myasthenia gravis: subgroup classification and therapeutic strategies.

P2888

s12883-016-0756-3

P304

225

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12883-016-0756-3

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Kimiaki Utsugisawa

Yuriko Nagane

P577

2016-11-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1049203012

http://www.w3.org/2001/XMLSchema#string

P698

27855632

http://www.w3.org/2001/XMLSchema#string

P921

myasthenia gravis

P932

5114805

http://www.w3.org/2001/XMLSchema#string

Response to treatment of myasthenia gravis according to clinical subtype

about

P2860

P2860

Response to treatment of myasthenia gravis according to clinical subtype

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921

P932